The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer

Urology

Volumn 51, Issue 5 SUPPL. A, 1998, Pages 125-130

  Yu, Hong Jeng ^a   Lai, Ming Kuen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER INCIDENCE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; RECTUM; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; PALPATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 0031806610     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00066-1     Document Type: Article

References (16)

1. Potosky A.L., Miller B.A., Albertsen P.C., Kramer B.S. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 273:1995;548-552.
2. Department of Health, the Executive Yuan: Cancer Registry Annual Report in Taiwan Area, 1991. Taipei: Department of Health, the Executive Yuan, pp 28-30, 1995.
3. Yu H.J., Chieh W.C., Tsai C.C., Lai M.K. Clinical efficacy of prostate-specific antigen testing in patients with prostatic disease. J Formo Jan Med Assoc. 95:1996;782-788.
4. Benson M.C., Whang I.S., Olsson C.A., McMahon D.J., Cooner W.H. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 147:1992;817-821.
5. Benson M.C., McMahon D.J., Cooner W.H., Olsson C.A. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density. World J Urol. 11:1993;206-213.
6. Littrup P.J., Williams C.R., Egglin T.K., Kane R.A. Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology. 179:1991;49-53.
7. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
8. Brawer M.K. The diagnosis of prostatic carcinoma. Cancer. 71:1993;899-905.
9. Catalona W.J., Richie J.P., deKernion J.B., Ahmann F.R., Ratliff T.L., Dalkin B.L., Kavoussi L.R., MacFarlane, Southwick P.C. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer receiver operating characteristic curves . J Urol. 152:1994;2031-2036.
10. Oesterling J.E. Prostate-specific antigen a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate . J Urol. 145:1991;907-923.
11. Bazinet M., Meshref A.W., Trudel C., Aronson S., Péloquin F., Nachabe M., Bégin L.R., Elhilali M.M. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology. 43:1994;44-51.
12. Rommel F.M., Agusta V.E., Breslin J.A., Huffnagle H.W., Pohl C.E., Sieber P.R., Stahl C.A. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol. 151:1994;88-93.
13. Cookson M.S., Floyd M.K., Ball T.P. Jr, Miller E.K., Sarosdy M.F. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol. 154:1995;1070-1073.
14. Nadler R.B., Humphery P.A., Smith D.S., Catalona W.J., Ratliff T.L. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 154:1995;407-413.
15. Yu H.J., Chiang G.C., Chiu T.Y., Lai M.K. The relationship between serum prostate specific antigen concentration and prostate volume. J Formos Med Assoc. 94:1995;666-670.
16. Oesterling J.E., Jacobsen S.J., Chute C.G., Guess H.A., Girman C.J., Panser M.A., Lieber M.M. Serum prostatic-specific antigen in a community-based population of healthy men Establishment of age-specific reference range . JAMA. 270:1993;860-864.